Health-Related Quality of Life Subdomains in Patients with Parkinson’s Disease: The Role of Gender

Table 3

Results of the gender-moderated multiple regression analysis on physical-functioning health-related quality of life ().

	B	SE	t
Intercept	15.38	8.38	1.84	0.068
Gender: male^b	0.01	10.04	<0.01	0.999
Age^a	0.01	0.18	0.03	0.974
Age gender	0.09	0.22	0.42	0.678
Disease duration	−0.27	0.39	−0.70	0.483
Disease duration gender	0.17	0.47	0.36	0.719
PANDA^a	0.18	0.47	0.39	0.696
PANDA gender	−0.36	0.55	−0.66	0.511
BDI-II	0.78	0.20	3.87	<0.001
BDI-II gender	0.01	0.26	0.03	0.978
NMSS^a	0.01	0.06	0.10	0.920
NMSS gender	0.20	0.07	2.75	0.006
UPDRS-III^a	0.95	0.26	3.69	<0.001
UPDRS-III gender	−0.59	0.31	−1.92	0.046
H&Y	3.98	3.09	1.29	0.200
H&Y gender	−2.06	3.81	−0.54	0.589
LEDD^a	0.01	0.01	3.23	0.001
LEDD gender	−0.01	0.01	−1.55	0.122
		Multiple R^2		0.63
		Adjusted R^2		0.60

Note. BDI-II = Beck’s Depression Inventory II; LEDD = levodopa equivalent daily dose; NMSS = Nonmotor Symptom Scale; UPDRS-III = Unified Parkinson’s Disease Rating Scale Part III. ^aGender was dummy coded with female gender as the baseline group; ^bvariable was mean-centered; ;;.